Hamdi Janazreh-Al
Jerusalem, JM, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
An unusual case of T-cell acute lymphoblastic leukemia in a patient with BCR-ABL positive chronic myeloid leukemia and Gaucher disease.
Journal: Annals of medicine and surgery (2012)
Published: June 14, 2021
Radiation induced delayed transverse myelitis and neurological deficit at tertiary care center.
Journal: Annals of medicine and surgery (2012)
Published: June 11, 2021
Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma.
Journal: Drug design, development and therapy
Published: May 14, 2021
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases.
Journal: American journal of hematology
Published: April 11, 2021
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials.
Journal: American journal of hematology
Published: March 22, 2021
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases.
Journal: European journal of haematology
Published: November 17, 2020
TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors.
Journal: Expert opinion on investigational drugs
Published: June 20, 2020
An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphoma.
Journal: Expert opinion on pharmacotherapy
Published: November 19, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026